BRPI0620431A8 - uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica - Google Patents

uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica Download PDF

Info

Publication number
BRPI0620431A8
BRPI0620431A8 BRPI0620431A BRPI0620431A BRPI0620431A8 BR PI0620431 A8 BRPI0620431 A8 BR PI0620431A8 BR PI0620431 A BRPI0620431 A BR PI0620431A BR PI0620431 A BRPI0620431 A BR PI0620431A BR PI0620431 A8 BRPI0620431 A8 BR PI0620431A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparation
film
applicator
forming polyurethane
plaster containing
Prior art date
Application number
BRPI0620431A
Other languages
English (en)
Inventor
Lehr Claus-Michael
Zurdo Schröder Ines
Franke Patrick
Bracht Stefan
Schäfer Ulrich
Original Assignee
Epinamics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05090347A external-priority patent/EP1800671A1/de
Application filed by Epinamics Gmbh filed Critical Epinamics Gmbh
Publication of BRPI0620431A2 publication Critical patent/BRPI0620431A2/pt
Publication of BRPI0620431A8 publication Critical patent/BRPI0620431A8/pt
Publication of BRPI0620431B1 publication Critical patent/BRPI0620431B1/pt
Publication of BRPI0620431B8 publication Critical patent/BRPI0620431B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica. a presente invenção refere-se ao uso de poliuretanos formadores de película que encontram utilização em agentes para o cuidado dos cabelos ou de misturas desses poliuretanos com outros polimeros em preparações farmacêuticas para a aplicação dérmica ou transdérmica de substâncias ativas, bem como emplastros e preparações farmacêuticas contendo esses poliuretanos para o cuidado dos cabelos.
BRPI0620431A 2005-12-23 2006-12-19 uso de poliuretanos lineares carboxilados, integralmente reagidos, neutralizados, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica BRPI0620431B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05090347.5 2005-12-23
EP05090347A EP1800671A1 (de) 2005-12-23 2005-12-23 Verwendung filmbildender Haarpflegepolymere und diese Polymere enthaltenden pharmazeutischen Zubereitungen und Pflaster
EP06090023 2006-02-03
EP06090023.0 2006-02-03
PCT/EP2006/012635 WO2007077029A1 (de) 2005-12-23 2006-12-19 Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster

Publications (4)

Publication Number Publication Date
BRPI0620431A2 BRPI0620431A2 (pt) 2011-11-08
BRPI0620431A8 true BRPI0620431A8 (pt) 2018-01-09
BRPI0620431B1 BRPI0620431B1 (pt) 2020-05-26
BRPI0620431B8 BRPI0620431B8 (pt) 2021-05-25

Family

ID=37744773

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620431A BRPI0620431B8 (pt) 2005-12-23 2006-12-19 uso de poliuretanos lineares carboxilados, integralmente reagidos, neutralizados, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica

Country Status (13)

Country Link
EP (1) EP1962815B1 (pt)
JP (1) JP5243262B2 (pt)
KR (1) KR101333100B1 (pt)
AT (1) ATE476969T1 (pt)
AU (1) AU2006332066B2 (pt)
BR (1) BRPI0620431B8 (pt)
CA (1) CA2633599C (pt)
DE (1) DE502006007664D1 (pt)
DK (1) DK1962815T3 (pt)
MX (1) MX2008008211A (pt)
PL (1) PL1962815T3 (pt)
RU (1) RU2437680C2 (pt)
WO (1) WO2007077029A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ541526A (en) 2003-01-24 2008-03-28 Stiefel Res Australia Pty Ltd Clindamycin phosphate foam
RU2470645C2 (ru) * 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
PT2400951T (pt) 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
US9345774B2 (en) * 2012-07-06 2016-05-24 Leo Pharma A/S Topical composition comprising a film-forming polymer for delivering an active ingredient to skin
ES2953955T3 (es) 2014-12-23 2023-11-17 Steven Hoffman Formulaciones transdérmicas
RU2702351C2 (ru) * 2015-03-09 2019-10-08 Басф Се Полиуретановые формованные изделия с превосходной гибкостью при низких температурах
CA3016464A1 (en) 2016-03-08 2017-09-14 Soo-Young Kang Long lasting cosmetic compositions
CN110891563B (zh) 2017-08-01 2022-09-02 久光制药株式会社 贴剂
CA3074845A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
AU2018333932B2 (en) 2017-09-13 2024-05-02 Living Proof, Inc. Long lasting cosmetic compositions
WO2019099966A1 (en) 2017-11-20 2019-05-23 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
CN112041365A (zh) 2018-04-27 2020-12-04 生活实验公司 持久性化妆品组合物
KR102590643B1 (ko) * 2019-01-31 2023-10-17 히사미쓰 세이야꾸 가부시키가이샤 첩부제
KR102298140B1 (ko) * 2019-05-31 2021-09-06 코스맥스 주식회사 폴리우레탄 및 에탄올을 포함하는 필-오프 타입의 색조 화장료 조성물
CN115103666A (zh) * 2020-02-11 2022-09-23 塔罗制药工业有限公司 包含去羟米松和他扎罗汀的组合物
DE202020003998U1 (de) 2020-07-21 2021-10-25 Inclusion Gmbh Filmbildende Sprühpflaster zur dermalen und transdermalen Applikation von Stoffen enthaltend funktionale Hilfsstoffe zur molekularen Komplexierung
EP4129292A1 (en) 2021-08-04 2023-02-08 OnychoPharm GmbH Formulation for substituted 2-aminothiazoles in the treatment of fungal and fungal-bacterial infections of the nail

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
EP0619111B2 (en) * 1993-04-06 2005-09-14 National Starch and Chemical Investment Holding Corporation Use of polyurethanes with carboxylate functionality for hair fixative applications
PT804151E (pt) * 1995-06-29 2003-01-31 Macrochem Corp Composicoes de polimeros formadores de peliculas lipofilicos e anfifilicos e sua utilizacao em sistema de administracao de agentes topicos e metodo de administracao de agentes a pele
US6365697B1 (en) * 1995-11-06 2002-04-02 Basf Aktiengesellschaft Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof
US6203812B1 (en) * 1998-06-29 2001-03-20 Hydromer, Inc. Hydrophilic polymer blends used to prevent cow skin infections
FR2823118B1 (fr) * 2001-04-04 2004-03-19 Lavipharm Lab Inc Nouvelle composition filmogene a usage topique et son utilisation pour la delivrance d'agents actifs
US20030143189A1 (en) * 2001-11-14 2003-07-31 Askill Ian N Therapy for topical diseases
US7854925B2 (en) * 2002-04-04 2010-12-21 Akzo Nobel N.V. Use of solubilized, anionic polyurethanes in skin care compositions
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
CA2444781A1 (en) * 2002-10-17 2004-04-17 Rolf C. Hagen Inc. Topical gel matrix
US20050063926A1 (en) * 2003-09-23 2005-03-24 Bathina Harinath B. Film-forming compositions for protecting animal skin

Also Published As

Publication number Publication date
BRPI0620431B1 (pt) 2020-05-26
ATE476969T1 (de) 2010-08-15
AU2006332066B2 (en) 2013-05-02
CA2633599C (en) 2015-02-10
CA2633599A1 (en) 2007-07-12
RU2008125099A (ru) 2010-01-27
MX2008008211A (es) 2008-09-03
KR20080081338A (ko) 2008-09-09
WO2007077029A1 (de) 2007-07-12
BRPI0620431B8 (pt) 2021-05-25
JP2009520741A (ja) 2009-05-28
KR101333100B1 (ko) 2013-11-27
RU2437680C2 (ru) 2011-12-27
DK1962815T3 (da) 2010-11-15
JP5243262B2 (ja) 2013-07-24
EP1962815B1 (de) 2010-08-11
AU2006332066A1 (en) 2007-07-12
BRPI0620431A2 (pt) 2011-11-08
PL1962815T3 (pl) 2011-02-28
DE502006007664D1 (de) 2010-09-23
EP1962815A1 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
BRPI0620431A8 (pt) uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
NO20063171L (no) Endoparasitisidale sammensetninger for topisk anvendelse
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
EA200901112A1 (ru) Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
BRPI0918868B8 (pt) compostos moduladores do receptor de nmda e composições compreendendo os mesmos
AR054227A1 (es) Composicion de principios activos
ATE497489T1 (de) Nichtsymmetrisches geliermittel
NO20064584L (no) Tetrahydropyridoindolderivater
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ZA200805027B (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
BRPI0909296A2 (pt) uso de pelo menos um princípio ativo, e, composições cosmética, farmacêutica e/ou dermatológica
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
BRPI0921491A2 (pt) uso terapêutico, dietético ou cosmético de compostos com atividade anti-apoptótica específica contra caspase-3, e composições contendo estes compostos
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
EA200901061A1 (ru) Фармацевтические и косметические композиции для ускорения процесса заживления ран и других поверхностных повреждений
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
BRPI0518554A2 (pt) uso de um inibidor de pde3
BRPI0511387A (pt) composição e seu uso
BRPI0905927A2 (pt) "composto, composição cosmética, comsposição farmacêutica, uso e processo de tratamento cosmético das matérias queratínicas"
DE50300126D1 (de) Coffein enthaltende Zusammensetzung als Hauptflegemittel
DK1617827T3 (da) Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 9/70

Ipc: A61K 8/02 (2006.01), A61K 8/87 (2006.01), A61K 9/7

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/05/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.